News Ticker

WIRE: Casa Verde Capital leads investment in Cannalysis testing lab

COSTA MESA, CA — Cannalysis, a cannabis testing laboratory, has announced a seed investment led by Casa Verde Capital.

As the premier cannabis testing lab in the market, Cannalysis harnesses technology to provide best-in-class service to some of the largest cultivators and brands in California.

With California’s adult-use regulations coming into effect next year, government-mandated third party testing will create a huge demand for services. However, many existing labs are not prepared to deal with this type of volume due to inferior technology, creating significant bottlenecks in getting clean product to market.

As such, Cannalysis is poised to fill this gap, with industry leading, guaranteed three business-day turnarounds.

Having built a custom platform from the ground up, Cannalysis streamlines the testing experience and puts all data in the client’s hands, providing real-time tracking and sample status updates.

Furthermore, beautiful and intuitive reporting enables Cannalysis to deliver the story behind the test results, something that customers genuinely appreciate.

In that vein, Kurvana, one of the largest cannabis brands in California had this to say on its relationship with Cannalysis: “They push our high volumes of samples through analysis without impact to quality or turnaround time, and they are willing to work with us to prioritize the results we need most. Placing value in collaboration and transparency, Cannalysis has exceeded our expectations and raised our standards.”

“With a tech-first approach, Cannalysis has quickly established itself as one of the leading lab platforms in California. This approach has also positioned Cannalysis to quickly scale and establish JV partners around the country,” said Karan Wadhera, managing partner at Casa Verde Capital.

Mr. Wadhera continued, “in fact, the first Cannalysis JV will come online in Portland early next year and we’re eager to secure new partnerships across the country to help extend the Cannalysis brand.”

Brian Lannon, CEO of Cannalysis, echoed these remarks, saying “we are at an inflection point for this industry and we are ready to expand. Having a marquee investor and strategic partner like Casa Verde, will be instrumental in helping us achieve our growth objectives.”


About Cannalysis
Founded in 2015, Cannalysis is a tech-forward, analytical cannabis laboratory. Using validated scientific methods to analyze cannabis products, Cannalysis is reinventing the way cannabis cultivators and brands interact with their lab partners, from convenient sample intake and quick turnarounds to real-time tracking and custom reporting. Cannalysis understands the importance of both accessing and displaying data, be it through an online client portal, a customized product label or a one-click post to Weedmaps.

About Casa Verde Capital
Casa Verde Capital is a venture firm that makes early stage investments in the cannabis industry. Led by a team of industry veterans and operators, Casa Verde focuses on ancillary businesses that “do not touch the plant.” This approach allows the firm to focus its efforts on businesses that can scale in an uncertain regulatory environment.

For more information and interview requests:
Lorna Donohoe < >

Casa Verde Capital, LLC Main: (323) 928-5090
12530 Beatrice Street Fax: (323) 928-5095
Los Angeles, CA 90066

Leave a comment